Skip to main content
SpringerLink
Log in

Anabolic Steroids

  • Chapter
Handbook of Substance Abuse

Abstract

Recreational and competitive athletes make use of a number of drugs and anabolic supplements to improve their performance and appearance. Anabolic steroids (AS) are the most commonly used and the most infamous of these compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abeyawardene, S. A., & Plant, T. M. (1989). Reconciliation of the paradox that testosterone replacement prevents the postcastration hypersecretion of follicle-stimulating hormone in male rhesus monkeys (Macaca mu-latta) with an intact central nervous system but not in hypothalamic-lesioned, gonadotropin-releasing hormone-replaced animals. Biology of Reproduction, 40, 578–584.

    Article  PubMed  CAS  Google Scholar 

  • Albert, D. J., Petrovic, D. M., & Walsh, M. L. (1989). Competitive experience activates testosterone-dependent social aggression toward unfamiliar males. Physiology Behavior; 45, 723–727.

    Article  PubMed  CAS  Google Scholar 

  • Albert, D. J., Jonik, R. H., Watson, N. V., Gorzalka, B. B., & Walsh, M. L. (1990). Hormone-dependent aggression in male rats is proportional to serum testosterone concentration but sexual behavior is not. Physiology Behavior, 48, 409–416.

    Article  PubMed  CAS  Google Scholar 

  • Alen, M., & Hakkinen, K. (1985). Physical health and fitness of an elite bodybuilder during 1 year of self-administering testosterone and anabolic steroids a case study. International Journal of Sports Medicine, 6, 24–29.

    Article  PubMed  CAS  Google Scholar 

  • Alen, M., Reinila, M., & Vihko, R. (1985). Response of serum hormones to androgen administration in power athletes. Medicine Science in Sports Exercise, 17, 354–359.

    CAS  Google Scholar 

  • Alen, M., Rahkila, E, Reinila, M., & Vihko, R. (1987). Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletes. American Journal of Sports Medicine, 15, 357–361.

    Article  PubMed  CAS  Google Scholar 

  • Annitto, W. J., & Layman, W. A. (1980). Anabolic steroids and acute schizophrenic episode: case reports. Journal of Clinical Psychiatry, 41, 143–144.

    PubMed  CAS  Google Scholar 

  • Archer, J. (1991). The influence of testosterone on human aggression. British Journal of Psychology, 82, 1–28.

    Article  Google Scholar 

  • Ariel, G., & Saville, W. (1972). Anabolic steroids: The physiologic effects of placebos. Medicine Science in Sports Exercise, 4, 124–126.

    Google Scholar 

  • Bagatell, C. J., Heiman, J. R., Matsumoto, A. M., Rivier, J. E., & Bremner, W. J. (1994). Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. Journal of Clinical Endocrinology Metabolism, 79, 561–567.

    Article  PubMed  CAS  Google Scholar 

  • Bahrke, M. S., Wright, J. E., O’Connor, J. S., Strauss, R. H., Catlin, D. H. (1990). Selected psychological characteristics of anabolic-androgenic steroid users. New England Journal of Medicine, 323, 834–835.

    PubMed  CAS  Google Scholar 

  • Bahrke, M. S., & Yesalis, C. E. (1994). Weight training. A potential confounding factor in examining the psychological and behavioural effects of anabolic-androgenic steroids [Review]. Sports Medicine, 18, 309–318.

    Article  PubMed  CAS  Google Scholar 

  • Bahrke, M. S., Yesalis, C. E., & Wright, J. E. (1990). Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males: A review. Sports Medicine, 10, 303–337.

    Article  PubMed  CAS  Google Scholar 

  • Bahrke, M., Wright, J., Strauss, R., & Catlin, D. (1992). Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. American Journal of Sports Medicine, 20, 717–724.

    Article  PubMed  CAS  Google Scholar 

  • Balducci, R., Toscano, V, Casilli, D., Maroder, M., Sciarra, F., & Boscherini, B. (1987). Testicular responsiveness following chronic administration of HCG (1500 IV every six days) in untreated hypogonadotropic hypogonadism. Hormone Metabolic Research, 19, 216–221.

    Article  CAS  Google Scholar 

  • Balestreri, R., Bertolini, S., Chiodini, G., & Ronzitti, M. (1971). Pituitary inhibitory and non-inhibitory effects of various anabolic 17-alkylating steroids. Archivo e Maragliano di Patologia e Clinica, 27, 123–135.

    CAS  Google Scholar 

  • Baranowska, B., Jeske, W, Niewiadomska, A., Rozbicka, G., Walczak, L., & Zgliczynski, S. (1983). Enhanced serum prolactin concentration after metoclopramide stimulation in idiopathic oligozoospermia and azoospermia. Andrologia, 15 (Special No.), 554–559.

    Article  PubMed  Google Scholar 

  • Barker, S. (1987). Oxymethalone and aggression. British Journal of Psychiatry, 151, 564.

    PubMed  CAS  Google Scholar 

  • Bhasin, S., Storer, T. W, Berman, N., Callegari, C., Clevenger, B., Phillips, J., Blunnell, T., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The effect of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine, 335, 1–7.

    Article  PubMed  CAS  Google Scholar 

  • Bjorkqvist, K., Nygren, T., Bjorklund, A. C., & Bjorkgvist, S. E. (1994). Testosterone intake and aggressiveness: Real effect or anticipation? Aggressive Behavior; 20, 18–26.

    Google Scholar 

  • Blank, D. M., Clark, R. V, Heymsfield, S. B., Rudman, D., & Blank, M. (1994). Endogenous opioids and hypogonadism in human obesity. Brain Research Bulletin, 34, 571–574.

    Article  PubMed  CAS  Google Scholar 

  • Bradley, A. J. (1987). Stress and mortality in the red-tailed phascogale, Phascogale calura (Marsupialia: Dasyuridae). General Comparative Endocrinology, 67, 85–100.

    Article  CAS  Google Scholar 

  • Brower K. (1989). Rehabilitation for anabolic-androgenic steroid dependence. Clinics in Sports Medicine, 1, 171–181.

    Google Scholar 

  • Brower, K. J. (1993a). Anabolic steroids: Potential for physical and psychological dependence. In C. Yesalis (Ed.), Anabolic steroids in sport and exercise (pp. 193–213 ). Champaign, IL: Human Kinetics.

    Google Scholar 

  • Brower, K. J. (1993b). Assessment and treatment of anabolic steroid withdrawal. In C. Yesalis (Ed), Anabolic steroids in sport and exercise (pp. 231–250 ). Champaign, IL: Human Kinetics.

    Google Scholar 

  • Brower, K. J., Blow, F. C., Beresford, T. P, & Fuelling, C. (1989). Anabolic-androgenic steroid dependence. Journal of Clinical Psychiatry, 50, 31–33.

    PubMed  CAS  Google Scholar 

  • Brower, K. J., Blow, E C., Eliopulos, G. A., & Beresford, T. P. (1989). Letters to the Editor: Anabolic androgenic steroids and suicide. American Journal of Psychiatry, 146, 1075.

    PubMed  CAS  Google Scholar 

  • Brower, K. J., Eliopulos, G. A., Blow, F. C., Catlin, D. H., & Beresford, T. P. (1990). Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. American Journal of Psychiatry, 147, 510–512.

    PubMed  CAS  Google Scholar 

  • Brower, K., Blow, F, Young, J., & Hill, E. (1991). Symptoms and correlates of anabolic-androgenic steroid dependence. British Journal of Addiction, 86, 759–768.

    Article  PubMed  CAS  Google Scholar 

  • Celotti, F., Avogadri, N., Melcangi, R. C, Milani, S., & Negri Cesi, P. (1984). Cyclophenil, a non-steroidal compound with a higher central than peripheral oestrogenic activity: Study of its effects on uterine growth and on some central parameters in castrated female rats. Acta Endocrinologica, 107, 340–345.

    PubMed  CAS  Google Scholar 

  • Choi, P. Y. L., Parrott, A. C., & Cowan, D. (1990). High-dose anabolic steroids in strength athletes: Effects upon hostility and aggression. Human Psychopharmacology, 5, 349–356.

    Article  Google Scholar 

  • Christiansen, K., Knussmann, R. (1987). Androgen levels and components of aggressive behavior in men. Hormones Behavior, 21, 170–180.

    Article  CAS  Google Scholar 

  • Clerico, A., Ferdeghini, M., Palombo, C., Leoncini, R., Del Chicca, M., Sardano, G., & Mariani, G. (1981). Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training. Journal of Nuclear Medicine Allied Sciences, 25, 79–88.

    CAS  Google Scholar 

  • Conacher, G., & Workman, D. (1989). Violent crime possibly associated with anabolic steroid use. American Journal of Psychiatry, 146, 679.

    PubMed  CAS  Google Scholar 

  • Dalby, J. (1992). Brief anabolic steroid use and sustained behavioral reaction. American Journal of Psychiatry, 149, 271–272.

    PubMed  CAS  Google Scholar 

  • Dalkin, A. C., Haisenleder, D. J., Ortolano, G. A., Ellis, T. R., & Marshall, J. C. (1989). The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression. Endocrinology, 125, 917–924.

    Article  PubMed  CAS  Google Scholar 

  • De Lignieres, B., & Mauvais-Jarvis, P. (1979). Hormones in depressive illness. The role of cortisol and sexual steroids. Annales de Biologie Clinique, 37, 49–57.

    PubMed  Google Scholar 

  • del Pozo, E., & Martin-Perez, J. (1985). Effect of dopamine receptor stimulation on the inhibition of LH pulsatility by a met-enkephaline (FK 33–824). Acta Neurochirurgica, 75, 88–90.

    Article  PubMed  Google Scholar 

  • Delville, Y., Mansour, K. M., & Ferris, C. E (1996). Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus. Physiology Behavior, 60, 25–29.

    Article  PubMed  CAS  Google Scholar 

  • Di Pasquale, M. G. (1991). Polypharmacy-Anabolic steroids and beyond. Drugs in Sports, Premier Issue, 1–2.

    Google Scholar 

  • Dunkel, L., & Huhtaniemi, I. (1985). Abnormal prolactin secretion in prepubertal boys with hypogonadotrophic hypogonadism-Possible involvement in regulation of testicular steroidogenesis. International Journal of Andrology, 8, 385–392.

    Article  PubMed  CAS  Google Scholar 

  • Egginton, S. (1987). Effects of an anabolic hormone on striated muscle growth and performance. P. Jlugers Archiv-European Journal of Physiology, 410, 349–355.

    Article  CAS  Google Scholar 

  • Falaschi, E, Frajese, G., Sciarra, E, Rocco, A., & Conti, C. (1978). Influence of hyperprolactinaemia due to metoclopramide on gonadal function in men. Clinical Endocrinology, 8, 427–433.

    Article  PubMed  CAS  Google Scholar 

  • Finkelstein, J. S., Spratt, D. I., O’Dea, L. S., Whitcomb, R., Klibanski, A., Schoenfeld, D., & Crowley, W. (1989). Pulsatile gonadotropin secretion after discontinuation of long-term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men. Journal of Clinical Endocrinology Metabolism, 69, 377–385.

    Article  PubMed  CAS  Google Scholar 

  • Foresta, C., Scanelli, G., Tramarin, A., & Scandellari, C. (1985). Serotonin but not dopamine is involved in the naloxone-induced luteinizing hormone release in man. Fertility Sterility, 43, 447–450.

    CAS  Google Scholar 

  • Frajese, G., Lazzari, R., Magnani, A., Moretti, C., Sforza, V, & Nerozzi, D. (1990), Neurotransmitter, opiodergic system, steroid-hormone interaction and involvement in the replacement therapy of sexual disorders. Journal of Steroid Biochemistry Molecular Biology, 37, 411–419.

    Article  CAS  Google Scholar 

  • Frankle, M. A., Eichberg, R., & Zachariah, S. B. (1988). Anabolic androgenic steroids and a stroke in an athlete: Case report. Archives of Physical Medicine Rehabilitation, 69, 632–633.

    CAS  Google Scholar 

  • Freinhar, J. P., & Alvarez, W. (1985). Androgen-induced Hypomania [letter]. Journal of Clinical Psychiatry, 46, 354–355.

    PubMed  CAS  Google Scholar 

  • Galligani, N., Renck, A., & Hansen, S. (1996). Personality profile of men using anabolic androgenic steroids. Hormones Behavior, 30, 170–175.

    Article  CAS  Google Scholar 

  • Giannini, J. A., Miller, N., & Kocjan, D. (1991). Treating steroid abuse: A psychiatric perspective. Clinical Pediatrics, 30, 538–542.

    Article  PubMed  CAS  Google Scholar 

  • Gitlin, M. J. (1994). Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. Journal of Clinical Psychiatry, 55, 406–413.

    PubMed  CAS  Google Scholar 

  • Glass, A. R. (1988). Pituitary-testicular reserve in men with low serum testosterone and normal serum luteinizing hormone. Journal of Andrology, 9, 224–230.

    PubMed  CAS  Google Scholar 

  • Goodman Gilman, A., Goodman, L. S., Rall, T. N., & Murad, F. (Eds.). (1985). The pharmacological basis of therapeutics, 7th edition. New York: Macmillan.

    Google Scholar 

  • Griggs, R. C., Kingston, W, Jozefowicz, R. E, Herr, B. E., Forbes, G., & Halliday, D. (1989). Effect of testosterone on muscle mass and muscle protein synthesis. Journal of Applied Physiology (United States), 66, 498–503.

    Google Scholar 

  • Hannan, C. J., Fried, K. E., Zold, A., Kettler, T. M., & Plymate, S. R. (1991). Psychological and serum homovanillic acid changes in men administered androgenic steroids. Psychoneuroendocrinology, 16, 335–343.

    Article  PubMed  CAS  Google Scholar 

  • Haupt, H. A., & Rovere, G. D. (1984). Anabolic steroids: A review of the literature. American Journal of Sports Medicine, 12, 469–484.

    Article  PubMed  CAS  Google Scholar 

  • Hobbs, C. J., Plymate, S. R., Bell, B. K., & Patience, T. H. (1991). The effect of androgens on glucose tolerance. Clinical Research, 39, 384A.

    Google Scholar 

  • Holma, P., & Adlercreutz, H. (1976). Effect of an anabolic steroid (metandienon) on plasma LH-FSH, and testosterone and on the response to intravenous administration of LRH. Acta Endocrinologica, 83, 856–864.

    PubMed  CAS  Google Scholar 

  • Jezova, D., Komadel, L., & Mikulaj, L. (1987). Plasma testosterone response to repeated human chorionic gonadotropin administration is increased in trained athletes. Endocrinologica Experimentalis, 21, 143–147.

    CAS  Google Scholar 

  • Kashkin, K. B., & Kleber, H. D. (1989). Hooked on hormones? An anabolic steroid addiction hypothesis. Journal of the American Medical Association, 262, 3166–3170.

    Article  PubMed  CAS  Google Scholar 

  • Kehoe, P. (1982). The relevance of anabolic steroids to middle distance running. Australian Track and Field Coaches Association (monograph).

    Google Scholar 

  • Kenyon, A. T. (1938). The effect of testosterone propionate on the genitalia, prostrate, secondary sex characters, and body weight in eunuchoidism. Endocrinology, 23, 121–134.

    Article  CAS  Google Scholar 

  • Kenyon, A. T. ( 1942, September). The first Josiah Macy Jr. Conference on bone and wound healing.

    Google Scholar 

  • Kenyon, A. T., Knowlton, K., Lotwin, G., & Sandford, I. (1942). Metabolic response of aged men to testosterone propionate. Journal of Clinical Endocrinology, 2, 690–695.

    Article  CAS  Google Scholar 

  • Kenyon, A. T., Knowlton, K., & Sandford, I. (1944). The anabolic effects of the androgens and somatic growth in man. Annals of Internal Medicine, 20, 632–654.

    CAS  Google Scholar 

  • Kilshawm, B. H., Harkness, R. A., Hobson, B. M., & Smith, A. W. (1975). The effects of large doses of the anabolic steroid, methandrostenolone, on an athlete. Clinical Endocrinology, 4, 537–541.

    Article  Google Scholar 

  • Kiraly, C. L., Collan, Y., & Alen, M. (1987). Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes. American Journal of Dermatopathology, 9, 515–519.

    Google Scholar 

  • Kletter, G. B., Foster, C. M., Beitins, 1. Z., Marshall, J., & Kelch, R. (1992). Acute effects of testosterone infusion and naloxone on luteinizing hormone secretion in normal men. Journal of Clinical Endocrinology Metabolism, 75, 1215–1219.

    CAS  Google Scholar 

  • Kletter, G. B., Foster, C. M., Brown, M. B., Beitins, 1., Marshall, J., & Kelch, R. (1994). Nocturnal naloxone fails to reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys. Journal of Clinical Endocrinology Metabolism, 79, 1147–1151.

    CAS  Google Scholar 

  • Kouri, E. M., Lukas, S. E., Pope, H. G., Jr., & Oliva, P. S. (1995). Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug and Alcohol Dependence, 40, 73–79.

    Article  PubMed  CAS  Google Scholar 

  • Kruskemper, H. L. (1968). Anabolic steroids (C. H. Doering, Trans.). New York: Academic Press.

    Google Scholar 

  • Kulin, H. E., & Reiter, E. O. (1972). Gonadotropin suppression by low dose estrogen in men-Evidence for differential effects upon FSH and LH. Journal of Clinical Endocrinology Metabolism, 35, 836–839.

    Article  PubMed  CAS  Google Scholar 

  • Labbate, L. A., & Pollack, M. H. (1994). Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Annals of Clinical Psychiatry, 6, 13–15.

    Article  PubMed  CAS  Google Scholar 

  • Lefavi, R. G., Reeve, T. G., & Newland, M. C. (1990). Relationship between anabolic steroid use and selected psychological parameters in male bodybuilders. Journal of Sport Behavior, 13, 157–166.

    Google Scholar 

  • Le Greves, P, Huang, W., Johansson, P, Thornwall, M., Zhou, Q., & Nyberg, E (1997). Effects of an anabolic-androgenic steroid on the regulation of the NMDA receptor NRI, NR2A and NR2B subunit mRNAs in brain regions of the male rat. Neuroscience Letters, 18, 61–64.

    Article  Google Scholar 

  • Lesch, K. P, Muller, U., Rupprecht, R., Kruse, K., & Schulte, H. (1989). Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression. Acta Psychiatrica Scandinavica, 79, 597–602.

    Article  PubMed  CAS  Google Scholar 

  • Libstag, K. (1990). The effects of anabolic steroids on measured personality traits of male weight trainers. Dissertation Abstracts International, 51, 40–91.

    Google Scholar 

  • Lindstrom, M., Nilsson, A., Katzman, P., Janzon, L., & Dymling, J. (1990). Use of anabolic-androgenic steroids among bodybuilders: Frequency and attitudes. Journal of Internal Medicine, 227, 407–41 I.

    Article  PubMed  CAS  Google Scholar 

  • Maddocks, S., & Setchell, B. P (1989). Effect of a single injection of human chorionic gonadotrophin on testosterone levels in testicular interstitial fluid, and in testicular and peripheral venous blood in adult rats. Journal of Endocrinology, 121, 311–316.

    Article  PubMed  CAS  Google Scholar 

  • Maggi, M., De Feo, M. L., Mannelli, M., Delitala, G., & Forti, G. (1985). Naloxone administration does not affect gonadotrophin secretion in male patients with isolated hypogonadotrophic hypogonadism. Acta Endocrinologica, 109, 153–157.

    PubMed  CAS  Google Scholar 

  • Malone, D., & Dimeff, R. (1992). The use of fluoxetine in depression associated with anabolic steroid withdrawal: A case series. Journal of Clinical Psychiatry, 53, 130–132.

    PubMed  Google Scholar 

  • Martikainen, H., Alen, M., Rahkila, P, & Vihko, R. (1986). Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes. Journal of Steroid Biochemistry, 25, 109–112.

    Article  PubMed  CAS  Google Scholar 

  • Masonis, A. E., & McCarthy, M. P. (1996). Direct interactions of androgenic/anabolic steroids with the peripheral benzodiazepine receptor in rat brain: Implications for the psychological and physiological manifestations of androgenic/anabolic steroid abuse. Journal of Steroid Biochemistry and Molecular Biology, 58, 551–555.

    Article  PubMed  CAS  Google Scholar 

  • McNutt, R. A., Ferenchick, G. S., Kirlin, E C., & Hamlin, N. J. (1988). Acute myocardial infarction in a 22year-old world class weight lifter using anabolic steroids. American Journal of Cardiology, 62, 164.

    Article  PubMed  CAS  Google Scholar 

  • Mikuma, N., Kumamoto, Y., Maruta, H., & Nitta, T. (1994). Role of the hypothalamic opioidergic system in the control of gonadotropin secretion in elderly men. Andrologia, 26, 39–45.

    Article  PubMed  CAS  Google Scholar 

  • Nakagawa, K., Obara, T., Matsubara, M., & Kubo, M. (1982). Relationship of changes in serum concentrations of prolactin and testosterone during dopaminergic modulation in males. Clinical Endocrinology, 17, 345–352.

    Article  PubMed  CAS  Google Scholar 

  • Nilsson, P. M., Moller, L., & Solstad, K. (1995). Adverse effects of psychosocial stress on gonadal function and insulin levels in middle-aged males. Journal of Internal Medicine, 137, 479–486.

    Article  Google Scholar 

  • Perry, P. J., Andersen, K. H., & Yates, W. R. (1990). Illicit anabolic steroid use in athletes: A case series analysis. American Journal of Sports Medicine, 18, 422–428.

    Article  PubMed  CAS  Google Scholar 

  • Perry, P. J., Yates, W. R., & Andersen, K. H. (1990). Psychiatric symptoms associated with anabolic steroids: A controlled, retrospective study. Annals of Clinical Psychiatry, 2, 11–17.

    Article  Google Scholar 

  • Pope, H. G., & Katz, D. L. (1987). Bodybuilder’s psychosis. Lancet, 1, 863.

    Article  PubMed  Google Scholar 

  • Pope, H. G., & Katz, D. L. (1988). Affective and psychotic symptoms associated with anabolic steroid use. American Journal of Psychiatry, 145, 487–490.

    PubMed  Google Scholar 

  • Pope, H. G., & Katz, D. L. (1990). Homicide and near-homicide by anabolic steroid users. Journal of Clinical Psychiatry, 51, 28–31.

    PubMed  Google Scholar 

  • Pope, H. G., Jr., Gruber, A. J., Choi, P., Olivardia, R., & Phillips, K. A. (1997). An underrecognized form of body dysmorphic disorder. Psychosomatics, 38, 548–557.

    Article  PubMed  Google Scholar 

  • Porcerelli, J. H., & Sandler, B. A. (1995). Narcissism and empathy in steroid users. American Journal of Psychiatry, 152, 1672–1674.

    PubMed  CAS  Google Scholar 

  • Prat, J., Gray, G. F., Stolley, P. D., & Coleman, J. W. (1977). Wilms’ tumor in an adult associated with androgen abuse. Journal of the American Medical Association, 237, 2322–2323.

    Article  PubMed  CAS  Google Scholar 

  • Rasmussen, D. D., Kennedy, B. P., Ziegler, M. G., & Nett, T. M. (1988). Endogenous opioid inhibition and facilitation of gonadotropin-releasing hormone release from the median eminence in vitro: potential role of catecholamines. Endocrinology, 123, 2916–2921.

    Article  PubMed  CAS  Google Scholar 

  • Repcekova, D., & Mikulaj, L. (1977). Plasma testosterone response to HCG in normal men without and after administration of anabolic drug. Endokrinologie, 69, 115–118.

    PubMed  CAS  Google Scholar 

  • Roberts, J. T., & Essenhigh, D. M. (1986). Adenocarcinoma of prostate in 40-year-old body-builder [Letter]. Lancet, 2, 742.

    Article  PubMed  CAS  Google Scholar 

  • Rockhold, R. W. (1993). Cardiovascular toxicity of anabolic steroids. Annual Review of Pharmacology Toxicology, 33, 497–520.

    Article  CAS  Google Scholar 

  • Rowlands, R. P., & Nicholson, G. W. (1929). Growth of left testicle with precocious sexual and bodily development (macro-genitosomia) Guy’s Hospital Report, 79, 401–408.

    Google Scholar 

  • Ruokonen, A., Alen, M., Bolton, N., & Vihko, R. (1985). Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. Journal of Steroid Biochemistry, 23, 33–38.

    Article  PubMed  CAS  Google Scholar 

  • Ryzhenkov, V. E., Bekhtereva, E. P., & Sapronov, N. S. (1974). Role of the limbic structures in the mechanism of action of glucocorticoids and estrogens on hypothalamic control of pituitary adrenocorticotropic and gonadotropic functions. Bulletin of Experimental Biology Medicine, 77, 362–265.

    CAS  Google Scholar 

  • Sacchi, E. (1895). A case of infantile gigantism (pedomacrosomia) with a tumor of the testicle. Riv. sper Freniat., 21, 149–161.

    Google Scholar 

  • Schatzberg, A. F., Rothschild, A. J., Langlais, P. J., Bird, E. D., & Cole, J. O. (1985). A corticosteroid/dopamine hypothesis for psychotic depression and related states. Journal of Psychiatric Research, 19, 57–64.

    Article  PubMed  CAS  Google Scholar 

  • Schlinger, B. A., & Callard, G. V. (1989). Aromatase activity in quail brain: correlation with aggressiveness. Endocrinology, 124, 437–43.

    Article  PubMed  CAS  Google Scholar 

  • Schulte, H. M., Hall, M. J., & Boyer, M. (1993). Domestic violence associated with anabolic steroid abuse [Letter to the editor]. American Journal of Psychiatry, 150, 348.

    PubMed  CAS  Google Scholar 

  • Schulte-Beerbuhl, M., & Nieschlag, E. (1980). Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate. Fertility Sterility, 33, 201–203.

    CAS  Google Scholar 

  • Sheckter, C. B., Matsumoto, A. M., & Bremner, W. J. (1989). Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. Journal of Clinical Endocrinology Metabolism, 68, 397–401.

    Article  PubMed  CAS  Google Scholar 

  • Siegel, J. M. (1986). The Multidimensional Anger Inventory. Journal of Personality Social Psychology, 51, 191–200.

    Article  CAS  Google Scholar 

  • Smals, A. G., Pieters, G. E, Smals, A. E., Hermus, A. R., Boers, G. H., Raemaekers, J. M., Benraad, T. J., & Kloppenborg, P. W. (1987). Reciprocal inhibition of the long-acting luteinizing hormone releasing hormone agonist Buserelin and human chorionic gonadotropin in stimulating Leydig cell steroidogenesis. Journal of Steroid Biochemistry, 28, 743–747.

    Article  PubMed  CAS  Google Scholar 

  • Soe, K. L., Soe, M., & Gluud, C. N. (1994). [Liver pathology associated with anabolic androgenic steroids]. Ugeskrift for Laeger, 156, 2585–2588.

    Google Scholar 

  • Spitz, I. M., LeRoith, D., Livshin, Y., Zylber-Haran, E., Trestian, S., Laufer, N., Ron, M., Palti, Z., & Schenker, J. (1980). Exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide in primary testicular failure. Fertility Sterility, 34, 573–580.

    CAS  Google Scholar 

  • Stannard, J. P., & Bucknell, A. L. (1993). Rupture of the triceps tendon associated with steroid injections. American Journal of Sports Medicine, 21, 482–485.

    Article  PubMed  CAS  Google Scholar 

  • Strauss, R., Liggett, M., & Lanese, R. (1985). Anabolic steroid use and perceived effects in ten weight-trained women athletes. Journal of the American Medical Association, 253, 2871–2873.

    Article  PubMed  CAS  Google Scholar 

  • Strauss, R. H., Wright, J. E., Finerman, G. A. M., & Catlin, D. H. (1983). Side effects of anabolic steroids in weight-trained men. Physician and Sports Medicine, 11, 86–88,91–93, 95, 98.

    Google Scholar 

  • Su, T. P, Pagliaro, M., Schmidt, P. J., Pickar, D., Wolkowitz, O., & Rubinow, D. R. (1993). Neuropsychiatric effects of anabolic steroids in male normal volunteers. Journal of the American Medical Association, 269, 2760–2764.

    Article  PubMed  CAS  Google Scholar 

  • Taylor, W. (1987). Anabolic steroids: A plea for control. Chiropractic Sports Medicine, 1, 47–52.

    Google Scholar 

  • Taylor, W. N. (1985). Hormonal manipulation. A new era of monstrous athletes. Jefferson, NC: McFarland.

    Google Scholar 

  • Tennant, E, Black, D. L., & Voy, R. O. (1988). Correspondence: Anabolic steroid dependence with opioid-type features. New England Journal of Medicine, 319, 578.

    Article  PubMed  CAS  Google Scholar 

  • Tepavcevic, D., Giljevic, Z., Korsic, M., Halimi, S., Suchanek, E., Jelic, T., Aganovic, I., Kozic, B., & Playsic, V. (1994). Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans. Journal of Endocrinological Investigation, 17, 1–5.

    PubMed  CAS  Google Scholar 

  • Tilzey, A., Heptonstall, J., & Hamblin, T. (1981). Toxic confusional state and choreiform movements after treatment with anabolic steroids. British Medical Journal, 285, 349–350.

    Article  Google Scholar 

  • Tinajero, J. C., Fabbri, A., & Dufau, M. L. (1992). Regulation of corticotropin-releasing factor secretion from Leydig cells by serotonin. Endocrinology, 130, 1780–1788.

    Article  PubMed  CAS  Google Scholar 

  • Van Vugt, D. A., & Meites, J. (1980). Influence of endogenous opiates on anterior pituitary function [Review]. Federation Proceedings, 39, 2533–2538.

    PubMed  Google Scholar 

  • Vanderstichele, H., Eechaute, W, Lacroix, E., & Leusen, I. (1989). Effect of tamoxifen on the activity of enzymes of testicular steroidogenesis. Steroids, 53, 713–726.

    Article  PubMed  CAS  Google Scholar 

  • Vermeulen, A. (1994). [Neuroendocrinological aspects of aging]. Verhandelingen-Koninklijke Academie voor Geneeskunde van Belgie, 56,267–280.

    Google Scholar 

  • Vermeulen, A., Kaufman, J. M. (1995). Ageing of the hypothalamo-pituitary-testicular axis in men. Hormone Research, 43, 25–28.

    Article  PubMed  CAS  Google Scholar 

  • Vida, J. A. (1969). Androgens and anabolic agents. New York: Academic Press.

    Google Scholar 

  • Wanderley, M. I., Favaretto, A. L., Valenca, M. M., Hattori, M., Wakabayaski, K., & Antunes-Rodrigues, J. (1989). Modulatory effects of adrenergic agonists on testosterone secretion from rat dispersed testicular cells or Percoll-purified Leydig cells. Brazilian Journal of Medical Biological Research, 22, 1421–1429.

    CAS  Google Scholar 

  • Webb, O. L., Laskarzewski, P. M., & Glueck, C. J. (1985). Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism, 33, 971–975. Abstract/Commentary: 1986 Year Book of Endocrinology, Article 8–8.

    Google Scholar 

  • Welder, A. A., & Melchert, R. B. (1993). Cardiotoxic effects of cocaine and anabolic-androgenic steroids in the athlete [Review]. Journal of Pharmacological Toxicological Methods, 29, 61–68.

    Article  CAS  Google Scholar 

  • Williams, T. D., Lightman, S. L., Johnson, M. R., Carmichael, D., & Bannister, R. (1989). Selective defect in gonadotrophin secretion in patients with autonomic failure. Clinical Endocrinology, 30, 285–292.

    Article  PubMed  CAS  Google Scholar 

  • Williamson, D. J., & Young, A. H. (1992). Psychiatric effects of androgenic and anabolic-androgenic steroid abuse in men: A brief review of the literature. Journal of Psychopharmacology, 6, 20–26.

    Article  PubMed  CAS  Google Scholar 

  • Wilson, 1. C., Prange, A. J., & Lara, P. P. (1974). Methyl-testosterone and imipramine in men: Conversion of depression to paranoid reaction. American Journal of Psychiatry, 131, 21–24.

    Google Scholar 

  • Wilson, J. (1988). Androgen abuse by athletes. Endocrinology Review, 9, 181–199.

    Article  CAS  Google Scholar 

  • Windsor, R., & Dumitru, D. (1989). Prevalence of anabolic steroid use by male and female adolescents. Medicine Science in Sports Exercise (United States), 21, 494–497.

    Google Scholar 

  • Wolkowitz, O. M. (1994). Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids [Review]. Psychoneuroendocrinology, 19, 233–255.

    Article  PubMed  CAS  Google Scholar 

  • Woodard, T. L., Burghen, G. A., Kitabchi, A. E., & Wilmas, J. A. (1981). Glucose intolerance and insulin resistance in aplastic anemia treated with oxymethalone. Journal of Clinical Endocrinology Metabolism, 53, 905–908.

    Article  PubMed  CAS  Google Scholar 

  • World Health Organization Task Force. (1990). Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet, 336, 955–959.

    Google Scholar 

  • Wroblewska, A. M. (1997). Androgenic-anabolic steroids and body dysmorphia in young men. Journal of Psychometric Research, 42, 225–234.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical and Health Education, University of Toronto, Toronto, Canada, K0K 3K0

    Mauro G. Di Pasquale

Authors
  1. Mauro G. Di Pasquale
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Ralph E. Tarter  & Peggy J. Ott  & 

  2. Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania, USA

    Robert T. Ammerman

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Di Pasquale, M.G. (1998). Anabolic Steroids. In: Tarter, R.E., Ammerman, R.T., Ott, P.J. (eds) Handbook of Substance Abuse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2913-9_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2913-9_34

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3297-6

  • Online ISBN: 978-1-4757-2913-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation